Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL714657 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL340648 | 0.92 | CA1 (0.33) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL29128993 | 0.92 | CA1 (0.33) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL29383198 | 0.92 | CA1 (0.33) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL345106 | 0.92 | CA1 (0.33) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL29131475 | 0.92 | CA1 (0.33) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL2963362 | 0.92 | CA1 (0.33) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL596237 | 0.92 | CA1 (0.33) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL23537582 | 0.91 | LMNA (0.38) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL16611 | 0.91 | LMNA (0.38) | CA1CA4CA5ACA5BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9339549-B2 | Cationic graft-copolymer for drug delivery system | ONISHI YASUHIKO (JP) | 2016-05-17 | — | — | US | disclosed |
| EP-1583782-B1 | CATIONIC GRAFT-COPOLYMER FOR NON-VIRAL GENE DELIVERY VECTOR | ONISHI YASUHIKO (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-20150072938-A1 | CATIONIC GRAFT-COPOLYMER FOR DRUG DELIVERY SYSTEM | ONISHI YASUHIKO (JP) | 2015-03-12 | — | — | US | disclosed |
| WO-2013125730-A2 | CATIONIC GRAFT-COPOLYMER FOR DRUG DELIVERY SYSTEM | ONISHI YASUHIKO (JP) | 2013-08-29 | — | — | WO | disclosed |
| US-20090215167-A1 | Cationic graft-copolymer for non-viral gene delivery vector | ONISHI YASUHIKO | 2009-08-27 | — | — | US | disclosed |
| US-7473733-B2 | Cationic graft-copolymer for non-viral gene delivery vector | ONISHI YASUHIKO | 2009-01-06 | — | — | US | disclosed |
| US-20050287110-A1 | Cationic graft-compolymer for non-viral gene delivery vector | ONISHI YASUHIKO | 2005-12-29 | — | — | US | disclosed |
| EP-1583782-A2 | CATIONIC GRAFT-COPOLYMER FOR NON-VIRAL GENE DELIVERY VECTOR | Onishi, Yasuhiko (JP) | 2005-10-12 | — | — | EP | disclosed |
| WO-2004065440-A2 | CATIONIC GRAFT-COPOLYMER FOR NON-VIRAL GENE DELIVERY VECTOR | ONISHI YASUHIKO (JP) | 2004-08-05 | — | — | WO | disclosed |
| US-4816540-A | Cationic graft-copolymer | ONISHI YASUHIKO (JP) | 1989-03-28 | — | — | US | disclosed |
| US-4002589-A | INVERSE EMULSION AND CERIUMIVSALT | CALGON CORPORATION (US) | 1977-01-11 | — | — | US | disclosed |
| US-3989656-A | Dextran-alkyl methacrylate graft composition for contact lens and corneas | KARME COMPANY LTD. (JA) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150072938-A1 | CATIONIC GRAFT-COPOLYMER FOR DRUG DELIVERY SYSTEM | OGFR, OXGR1, OGFRL1 | CA1 2426/4885CA4 3084/4885CA5A 2058/4885 |
| US-20050287110-A1 | Cationic graft-compolymer for non-viral gene delivery vector | NONO, OGFR, OGFOD1 | CA1 2897/4885CA4 3104/4885CA5A 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.